DT2219
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for DT2219, covering 2020-01-13 to 2020-01-13. Get the full timeline:
Most recent: Clinical Trial Update: HM2014-26 DT2219 for Relapsed or Refractory B-Lineage Leukemia or Lymphoma [Phase 1, Phase 2]